Indivior PLC (LON:INDV - Get Free Report)'s stock price crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 712.52 ($9.03) and traded as high as GBX 787.50 ($9.98). Indivior shares last traded at GBX 769 ($9.75), with a volume of 273,799 shares traded.
Analysts Set New Price Targets
Separately, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 1,500 ($19.01) target price on shares of Indivior in a research note on Thursday, September 5th.
View Our Latest Research Report on INDV
Indivior Stock Performance
The company has a debt-to-equity ratio of 2,790.00, a current ratio of 0.85 and a quick ratio of 1.52. The firm has a fifty day moving average price of GBX 712.52 and a two-hundred day moving average price of GBX 992. The stock has a market capitalization of £1.00 billion, a PE ratio of -979.38, a P/E/G ratio of -5.57 and a beta of 0.19.
Indivior Company Profile
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Recommended Stories
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.